Add movement disorders patients to the long list of people whose health could suffer under the Trump administration’s proposal to loosen Medicare protections on six classes of medications for high-risk diseases.
An upcoming meeting will give people with movement disorders a chance to tell Food and Drug Administration regulators their story – the story of their physical symptoms as well as their emotional ones.
Last month, the federal government proposed changes to Medicare’s billing rules. The net effect: Doctors will spend less time with their patients. As a physician myself, I know that’s not necessarily a good thing.
An influential calculation of how new drugs impact annual spending is flawed – and patients may be paying the price in reduced access to innovative medicine.
It's not easy to tell the world you're "different." Katie Wilson, from Broomfield, wants to have a conversation about her Tourette Syndrome with anyone who's willing to truly listen.